AngioDynamics, Inc. (ANGO)
15.78
+0.03
(+0.19%)
USD |
NASDAQ |
Aug 24, 16:00
15.78
0.00 (0.00%)
After-Hours: 20:00
AngioDynamics Debt to Equity Ratio : 0.0641 for May 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| May 31, 2026 | 0.0641 |
| February 28, 2026 | 0.0657 |
| November 30, 2025 | 0.0669 |
| August 31, 2025 | 0.0537 |
| May 31, 2025 | 0.0216 |
| February 28, 2025 | 0.0237 |
| November 30, 2024 | 0.0263 |
| August 31, 2024 | 0.0276 |
| May 31, 2024 | 0.0288 |
| February 29, 2024 | 0.0181 |
| November 30, 2023 | 0.0105 |
| August 31, 2023 | 0.011 |
| May 31, 2023 | 0.1455 |
| February 28, 2023 | 0.1387 |
| November 30, 2022 | 0.1367 |
| August 31, 2022 | 0.1362 |
| May 31, 2022 | 0.076 |
| February 28, 2022 | 0.0766 |
| November 30, 2021 | 0.0774 |
| August 31, 2021 | 0.0782 |
| May 31, 2021 | 0.0677 |
| February 28, 2021 | 0.0886 |
| November 30, 2020 | 0.1096 |
| August 31, 2020 | 0.1107 |
| May 31, 2020 | 0.1108 |
| Date | Value |
|---|---|
| February 29, 2020 | 0.0392 |
| November 30, 2019 | 0.0075 |
| August 31, 2019 | 0.0083 |
| May 31, 2019 | 0.2145 |
| February 28, 2019 | 0.2402 |
| November 30, 2018 | 0.2625 |
| August 31, 2018 | 0.166 |
| May 31, 2018 | 0.1689 |
| February 28, 2018 | 0.1724 |
| November 30, 2017 | 0.1803 |
| August 31, 2017 | 0.1837 |
| May 31, 2017 | 0.187 |
| February 28, 2017 | 0.1834 |
| November 30, 2016 | 0.2201 |
| August 31, 2016 | 0.2304 |
| May 31, 2016 | 0.2376 |
| February 29, 2016 | 0.2295 |
| November 30, 2015 | 0.2445 |
| August 31, 2015 | 0.2493 |
| May 31, 2015 | 0.2526 |
| February 28, 2015 | 0.2739 |
| November 30, 2014 | 0.2854 |
| August 31, 2014 | 0.262 |
| May 31, 2014 | 0.2657 |
| February 28, 2014 | 0.2583 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Boston Scientific Corp. | 0.5064 |
| Penumbra, Inc. | 0.139 |
| Abbott Laboratories | 0.638 |
| Alphatec Holdings, Inc. | 52.37 |
| AtriCure, Inc. | 0.1437 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 267.16M |
| Total Liabilities (Quarterly) | 96.34M |
| Shareholders Equity (Quarterly) | 170.82M |
| Current Ratio | 2.183 |
| Net Debt Paydown Yield | -0.27% |